Non-small-cell lung cancer (NSCLC) is the most common type of lung cancer, and represents one of the largest oncology therapy markets. In this infographic, Clarivate experts provide a snapshot of NSCLC epidemiology data, including:
- Projected market size by 2032
- Granular patient population by stage at diagnosis
- Top comorbidities based on U.S. claims-based data
- Insights into drug-treated vs non-drug treated populations
